|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 209/52 | (2006.01) |
| C07D 209/02 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 5/02 | (2006.01) | ||
| C07K 5/08 | (2006.01) | ||
| C07K 5/10 | (2006.01) |
| (11) | Patento numeris | 2368877 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10185132.7 |
| Europos patento paraiškos padavimo data | 2001-08-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-05-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 229398 P | 2000-08-31 | US | |
| 277641 P | 2001-03-21 | US |
| (72) |
Babine, Robert Edward, US
Chen, Shu-Hui, US
Lamar, Jason Eric, US
Snyder, Nancy June, US
Sun, Xicheng, US
Tebbe, Mark Joseph, DE
Victor, Frantz, US
Wang, May Q., US
Yip, Mai Yee Yvonne, US
Collado, Ivan, ES
Garcia-Paredes, Cristina, ES
Parker III, Samuel Raymond, US
Jin, Ling, US
Guo, Deqi, US
Glass, John Irvin, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | Peptidomimetic protease inhibitors and intermediates for their preparation As treatment for HCV infection |
| Peptidomimetic protease inhibitors and intermediates for their preparation As treatment for HCV infection |